DORCEF-S

This brand name is authorized in Nigeria.

Active ingredients

The drug DORCEF-S contains a combination of these active pharmaceutical ingredients (APIs):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone
2	Sulbactam UNII DKQ4T82YE6 - SULBACTAM SODIUM
	Read more about Sulbactam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101177	Injection	Dorcef-S Injection INJ 1000 mg; 500 mg 1 vial	White to off white crystalline powder filled in 20ml clear glass vials NF-PP-392026 DORCEF-S INJECTION Ceftriaxone 1000mg + Sulbactam 500mg Ceftriaxone 1000mg, Sulbactam 500mg, WFI Drugs Imported Products 1Vial POM 1 11/29/2023 ARTEMIS LIFE SCIENCES NIG LTD, 2EB, OPPOSITE ASWANI MARKET, OSOLO WAY, ASWANI OSHODI INDUSTRIAL SCHEME ISOLO LAGOS 7015431928 gaminiwei.bourdillon@artemislife.com SHAMSHREE LIFESCIENCES LIMITED, Plot No. 11, Industrial Area, Katha-Bhatolikalan,Baddi – 173205 (H.P.), India, India	30/01/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD63		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD63

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101177